Moody's Investors Service has assigned an initial "A1" revenue bond rating to Birmingham-based UAB Medicine's series 2016A and 2016B bonds, affecting approximately $344 million.
The rating assignment is based on a number of factors, including UAB Medicine's solid market share in Birmingham, as well as its affiliations with Birmingham-based University of Alabama School of Medicine, the University of Alabama at Birmingham and Tuscaloosa-based University of Alabama System.
The outlook is positive, reflecting Moody's Investors Service's expectation that UAB Medicine will continue to capitalize on recent organizational changes and continue to increase operating cash flow.